A US based global Pharma and Consumer Healthcare company approached Freyr for market and product based Regulatory intelligence, primary intelligence strategy for Africa, Middle East, Latin America (LATAM) and Asia markets. Performing gap analysis in primary and secondary sources and addressing them were the major challenges initially, Freyr had to encounter.

This case study explains how Freyr customized its in-house Regulatory intelligence tool – Freyr INSIGHT, which enabled client for multi-country filings.